Aurobindo Pharma
| Type | Public |
|---|---|
| NSE: AUROPHARMA BSE: 524804 | |
| Industry | Pharmaceuticals |
| Founded | 1986 |
| Founders | V. Ramprasad Reddy K. Nityananda Reddy |
| Headquarters | Hyderabad, Telangana, India |
| Products | |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | 23,000 (2020) |
| Subsidiaries | Lannett Company |
| Website | www |
| Footnotes Financials as of 31 March 2025. | |
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca.